sumfun is correct. Management said they have no reason to issue any shares. Stay on top of things and listen to the CEO not yahoo posters. The company has had an open shelf since 2009 and never touched it. it means nothing.
A "Big" stock issuance means nothing, if you are getting value for value. It could be a plus if the street believes the value obtained is greater the stock offered. It also doesn't have to be a public financing. A stock swap, could be what's used.
In any case, the shelf does not need to be used for financing ongoing operations, which is what shareholders fear as it only dilutes. The shelf, if used, will instead, bring value for value and could very well increase shareholder value.
No need to be scared of the shelf near term, with 30M in the bank.
no, actually YOU should stay current: why do you think the filed a shelf registration earlier this year ??
the 30 million isnt going to be enough to buy any company with a serious product in development....plus they still have a year of overhead to pay before they see dollar one in Lympho sales...
stand by for a big stock issuance....
Ok..So they have 30 million dollars (Should be able to close the first pipeline acquisition "in coming months". Pursuing late stage opportunities for high profile disorders, w/significant unmet needs and large, addressable patient populations. Oncology, neurology and cardiology all being considered.....)Oh really...I don't know of many Biotechs late stage that have a market cap less than 30 million.....And with no revenue coming in yet how are they going to advance this phantom company????